Details for Patent: 8,969,336
Which drugs does patent 8,969,336 protect, and when does it expire?
Patent 8,969,336 protects XOSPATA and is included in one NDA.
This patent has fifty patent family members in twenty-nine countries.
Summary for Patent: 8,969,336
| Title: | Diamino heterocyclic carboxamide compound |
| Abstract: | Provided is a compound useful as an inhibitor against the kinase activity of EML4-ALK fusion protein. As a result of intensive and extensive studies on compounds having inhibitory activity against the kinase activity of EML4-ALK fusion protein, the present inventors found that the diamino heterocyclic carboxamide compounds of the present invention had inhibitory activity against the kinase activity of EML4-ALK fusion protein. By this finding, the present invention was completed. The compounds of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, such as lung cancer, non-small cell lung cancer, and small cell lung cancer. |
| Inventor(s): | Itsuro Shimada, Kazuo Kurosawa, Takahiro Matsuya, Kazuhiko Iikubo, Yutaka Kondoh, Akio Kamikawa, Hiroshi Tomiyama, Yoshinori Iwai |
| Assignee: | Kotobuki Seiyaku Co Ltd , Astellas Pharma Inc |
| Application Number: | US13/266,164 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,969,336 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 8,969,336
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | XOSPATA | gilteritinib fumarate | TABLET;ORAL | 211349-001 | Nov 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,969,336
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2009-113936 | May 8, 2009 |
| PCT Information | |||
| PCT Filed | May 06, 2010 | PCT Application Number: | PCT/JP2010/057751 |
| PCT Publication Date: | November 11, 2010 | PCT Publication Number: | WO2010/128659 |
International Family Members for US Patent 8,969,336
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2428508 | ⤷ Start Trial | 301028 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2428508 | ⤷ Start Trial | 122020000004 | Germany | ⤷ Start Trial |
| European Patent Office | 2428508 | ⤷ Start Trial | PA2020002 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
